Peripheral Artery Disease Latest Advances

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Journal: Annals of medicine

Published: April 15, 2026

The impact of the gut microbiome on the development of atherosclerosis and peripheral arterial disease: A narrative review.

Journal: Przeglad epidemiologiczny

Published: April 14, 2026

HbA1c as an Independent Predictor of Peripheral Artery Disease: Nonlinear Threshold and Causal Evidence from NHANES and Mendelian Randomization.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: April 13, 2026

Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes.

Journal: Current diabetes reports

Published: April 10, 2026

An exploration of factors affecting timely referral of patients with chronic limb-threatening ischaemia.

Journal: Annals of the Royal College of Surgeons of England

Published: April 09, 2026

Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment.

Journal: Journal of the American Heart Association

Published: April 09, 2026

Acute Care Outcomes and 30-Day Readmission Among Patients With Peripheral Artery Disease Hospitalized for Acute Heart Failure: A Retrospective Cohort Study.

Journal: Cardiology in review

Published: April 07, 2026

Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling.

Journal: Circulation

Published: April 07, 2026

Association between novel hematological inflammatory indices and prevalent peripheral arterial disease: A cross-sectional analysis from the national health and nutrition examination survey.

Journal: Science progress

Published: April 07, 2026

Prevalence of Peripheral Arterial Disease in Patients with COPD Depending on Disease Stage, Systemic Inflammation, and Exacerbation Rate

Journal: Pneumologie (Stuttgart, Germany)

Published: April 02, 2026

The associations between lower extremity peripheral arterial disease and immune-inflammatory biomarkers.

Journal: International angiology : a journal of the International Union of Angiology

Published: April 01, 2026

Impact of lipid-rich plaques in the femoropopliteal artery on limb outcomes in patients undergoing endovascular therapy.

Journal: Vascular medicine (London, England)

Published: March 31, 2026

Peripheral Artery Disease Latest Advances

Find the Latest Research About Peripheral Artery Disease

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

Prognostic implications of single antiplatelet therapy in individuals developing diabetic foot disease with concurrent peripheral arterial disease.

The impact of the gut microbiome on the development of atherosclerosis and peripheral arterial disease: A narrative review.

The impact of the gut microbiome on the development of atherosclerosis and peripheral arterial disease: A narrative review.

HbA1c as an Independent Predictor of Peripheral Artery Disease: Nonlinear Threshold and Causal Evidence from NHANES and Mendelian Randomization.

HbA1c as an Independent Predictor of Peripheral Artery Disease: Nonlinear Threshold and Causal Evidence from NHANES and Mendelian Randomization.

Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes.

Correction: Glucagon-Like Peptide-1 and Dual Incretin Agonists in Type 2 Diabetes with Peripheral Artery Disease: A Systematic Review and Meta-Analysis of Vascular, Cardiovascular, Metabolic, and Mortality Outcomes.

An exploration of factors affecting timely referral of patients with chronic limb-threatening ischaemia.

An exploration of factors affecting timely referral of patients with chronic limb-threatening ischaemia.

Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment.

Out-of-Pocket Costs and Antihypertensive Medication Use Among Veterans: A Natural Experiment.

Acute Care Outcomes and 30-Day Readmission Among Patients With Peripheral Artery Disease Hospitalized for Acute Heart Failure: A Retrospective Cohort Study.

Acute Care Outcomes and 30-Day Readmission Among Patients With Peripheral Artery Disease Hospitalized for Acute Heart Failure: A Retrospective Cohort Study.

Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling.

Olfactory Receptor Activation Reduces Platelet Reactivity and Arterial Thrombosis Through Actin Cytoskeleton Remodeling.

Association between novel hematological inflammatory indices and prevalent peripheral arterial disease: A cross-sectional analysis from the national health and nutrition examination survey.

Association between novel hematological inflammatory indices and prevalent peripheral arterial disease: A cross-sectional analysis from the national health and nutrition examination survey.

Prevalence of Peripheral Arterial Disease in Patients with COPD Depending on Disease Stage, Systemic Inflammation, and Exacerbation Rate

Prevalence of Peripheral Arterial Disease in Patients with COPD Depending on Disease Stage, Systemic Inflammation, and Exacerbation Rate

The associations between lower extremity peripheral arterial disease and immune-inflammatory biomarkers.

The associations between lower extremity peripheral arterial disease and immune-inflammatory biomarkers.

Impact of lipid-rich plaques in the femoropopliteal artery on limb outcomes in patients undergoing endovascular therapy.

Impact of lipid-rich plaques in the femoropopliteal artery on limb outcomes in patients undergoing endovascular therapy.